Physician profile
Daniel Coll
NPI 1538132014
$11,922.52
in general payments reported to CMS, 2019-2025
18 companies · $9,987 in 2025
The $9,987 reported for 2025 was more than what 99% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $619 · 2022: $414 · 2023: $311 · 2024: $591 · 2025: $9,987.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $5,945 · Food and Beverage: $2,113 · Travel and Lodging: $2,082 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $750.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $5,944.88 |
| Food and Beverage | $2,113.33 |
| Travel and Lodging | $2,081.52 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $750.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medical Device Business Services, INC. | $6,652.63 | 2021-2025 | Stratafix, Monovisc, Orthovisc |
| Ethicon US, LLC | $2,018.20 | 2025 | |
| Siemens Medical Solutions USA, INC. | $983.00 | 2024-2025 | Ciartic Move |
| Heron Therapeutics, INC. | $580.42 | 2021 | |
| Zimmer Biomet Holdings, INC. | $218.76 | 2025 | Dvr Anatomic Kickstand |
| Pacira Pharmaceuticals Incorporated | $204.46 | 2022-2025 | Iovera |
| Endo USA, INC. | $168.02 | 2024-2025 | Xiaflex |
| Si-Bone, INC. | $148.41 | 2022 | |
| Radius Health, INC. | $132.88 | 2025 | Tymlos |
| Bioventus LLC | $130.20 | 2023 | Durolane |
| Ethicon INC. | $129.94 | 2025 | Ethicon, Stratafix |
| Astrazeneca Pharmaceuticals Lp | $124.99 | 2024 | Fasenra |
| Djo, LLC | $118.21 | 2024 | Procare |
| Orthalign INC | $101.00 | 2023 | Orthalign Plus |
| Smith+Nephew, INC. | $94.83 | 2024 | Real Intelligence, Journey II |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Depuy Synthes Sales INC. | $48.56 | 2025 | Monovisc |
| Vertex Pharmaceuticals Incorporated | $34.11 | 2024 | |
| Boston Scientific Corporation | $33.90 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Daniel Coll listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.